ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000265205.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.011768596	Resistant
ENSG00000265205.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.039254698	Sensitive